Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
Prostate Cancer
Trial Locations (17)

Unknown

RECRUITING

Research Site, Arkhangelsk

NOT_YET_RECRUITING

Research Site, Barnaul

NOT_YET_RECRUITING

Research Site, Chelyabinsk

NOT_YET_RECRUITING

Research Site, Irkutsk

NOT_YET_RECRUITING

Research Site, Krasnoyarsk

NOT_YET_RECRUITING

Research Site, Moscow

RECRUITING

Research Site, Moscow

NOT_YET_RECRUITING

Research Site, Nizhny Novgorod

NOT_YET_RECRUITING

Research Site, Obninsk

NOT_YET_RECRUITING

Research Site, Omsk

NOT_YET_RECRUITING

Research Site, Saint Petersburg

NOT_YET_RECRUITING

Research Site, Sochi

NOT_YET_RECRUITING

Research Site, Tomsk

NOT_YET_RECRUITING

Research Site, Tver'

NOT_YET_RECRUITING

Research Site, Tyumen

NOT_YET_RECRUITING

Research Site, Ufa

NOT_YET_RECRUITING

Research Site, Yekaterinburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY